Sectors
CVKD
Cadrenal Therapeutics, Inc.
1.76
1 x 1.73
10 x 1.79
bid
ask
+
0.22
14.22%
02:11 PM
timesize
| Ytd | -74.06% | |
| 1y | -86.43% |
1.46
day range
2.29
1.46
52 week range
14.64
| Open | 1.64 | Prev Close | 1.54 | Low | 1.46 | High | 2.29 | Mkt Cap | 6.25M |
| Vol | 20.00M | Avg Vol | 68.13K | EPS | -4.88 | P/E | N/A | Forward P/E | -3.02 |
| Beta | 1.84 | Short Ratio | 1.17 | Inst. Own | 4.75% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-21 | 50-d Avg | 2.30 | 200-d Avg | 5.74 | 1yr Est | 35.67 |
| Income Statement | |||
| Operating Expenses | 3.34M | ||
| Research and Development Expense | 705.15K | ||
| Selling, General and Administrative Expense | 2.63M | ||
| Operating Income | -3.34M | ||
| Net Income | -3.32M | ||
| Net Income Common Stock | -3.32M | ||
| Net Income Common Stock (USD) | -3.32M | ||
| Consolidated Income | -3.32M | ||
| Earnings per Basic Share | -1.14 | ||
| Earnings per Basic Share (USD) | -1.14 | ||
| Earnings per Diluted Share | -1.14 | ||
| Earning Before Interest & Taxes (EBIT) | -3.32M | ||
| Earning Before Interest & Taxes (USD) | -3.32M | ||
| Weighted Average Shares | 2.91M | ||
| Weighted Average Shares Diluted | 2.91M | ||
| Balance Sheet | |||
| Cash and Equivalents | 2.39M | ||
| Cash and Equivalents (USD) | 2.39M | ||
| Current Assets | 5.58M | ||
| Property, Plant & Equipment Net | 2.68K | ||
| Total Assets | 5.59M | ||
| Current Liabilities | 1.50M | ||
| Total Liabilities | 1.50M | ||
| Accumulated Retained Earnings (Deficit) | -44.78M | ||
| Shareholders Equity | 4.09M | ||
| Shareholders Equity (USD) | 4.09M | ||
| Assets Non-Current | 4.84K | ||
| Trade and Non-Trade Payables | 871.91K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 504.00 | ||
| Net Cash Flow from Financing | 2.31M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 80.00K | ||
| Capital Expenditure | 1.44K | ||
| Issuance (Purchase) of Equity Shares | 2.31M | ||
| Net Cash Flow from Investing | 1.44K | ||
| Net Cash Flow from Operations | -2.23M | ||
| Share Based Compensation | 672.10K | ||